Oncology Early Phase / Multiple Disease Site Hematologic Malignancies Early Phase Team Lymphoma NHL T-Cell Lymphoma Relapsed/Refractory 1 or more prior lines
Categories
Protocols
IIT-ATALLAH-MCW-XEN21 Phase I OPEN TO ACCRUAL
MCW-XEN21: A Phase 1 Study of XmAb18968 (CD3-CD38) for the Treatment of Patients with Relapsed/Refractory CD38 Positive Acute Leukemia and T Cell Lymphoblastic Lymphoma